Heat shock protein as molecular targets for breast cancer therapeutics.
about
Mini-chaperones: potential immuno-stimulators in vaccine designProstate cancer relevant antigens and enzymes for targeted drug deliveryHeat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an updateComparison of the expression of 5 heat shock proteins in benign and malignant salivary gland tumor tissuesChronic inflammation in cancer development.Regulation of Greatwall kinase by protein stabilization and nuclear localizationNovel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig2-positive glioma tumor-initiating cells.Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapyHeat shock protein 90 is critical for regulation of phenotype and functional activity of human T lymphocytes and NK cells.Overcoming HSP27-mediated resistance by altered dimerization of HSP27 using small molecules.The significance of heat shock proteins in breast cancer therapy.Protein content and functional characteristics of serum-purified exosomes from patients with colorectal cancer revealed by quantitative proteomics.Grating coupled SPR microarray analysis of proteins and cells in blood from mice with breast cancer.Targeting heat shock proteins by phenethyl isothiocyanate results in cell-cycle arrest and apoptosis of human breast cancer cells.HSP90 expression and its association with wighteone metabolite response in HER2-positive breast cancer cells.Gene expression regulation by heat-shock proteins: the cardinal roles of HSF1 and Hsp90.Rosmarinic acid and siRNA combined therapy represses Hsp27 (HSPB1) expression and induces apoptosis in human glioma cells.
P2860
Q27005634-E9551B62-CB75-4A56-9EF5-C21777F639EEQ27013843-9372AC20-C2E7-49F3-AB56-9193CB472D85Q28272905-5A39FEC2-404D-4AEC-BFC7-FEDE9DE22390Q34340255-5305E41F-5489-424D-A4B6-3BF786F7D2FDQ35928265-3D70C5DD-92A1-4EAA-B701-2F47BFAF403FQ36182488-3459FD9A-9BCA-46B8-88BC-994AB63B7205Q36847206-4D7F2F73-B69F-4FE8-9961-3319ECC84617Q36877600-67DD5823-F50C-47C9-8ACD-244FE46B46F4Q37286051-1F3D61C6-718F-45AB-8301-690CBF71B95AQ37619720-5B88CD25-61EE-41B1-B142-ED4D62ED1E82Q38100745-27660A2C-A40B-4C16-872A-6FDA8CD0C81DQ38385118-0ED485A4-57C8-45F9-B815-B80E7BA51C7BQ38821891-24F52FD5-D183-4C46-A0A9-401182229ED9Q39175428-8473705D-AC70-4D22-95A2-66A96A9126C5Q42747804-65ABCEC0-9A01-4686-A5A2-21C87C0B4372Q47259561-699270FB-2037-4F79-A969-EA55640411BCQ52600379-2CD1230C-2870-43B9-B360-2AC492480850
P2860
Heat shock protein as molecular targets for breast cancer therapeutics.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Heat shock protein as molecular targets for breast cancer therapeutics.
@en
Heat shock protein as molecular targets for breast cancer therapeutics.
@nl
type
label
Heat shock protein as molecular targets for breast cancer therapeutics.
@en
Heat shock protein as molecular targets for breast cancer therapeutics.
@nl
prefLabel
Heat shock protein as molecular targets for breast cancer therapeutics.
@en
Heat shock protein as molecular targets for breast cancer therapeutics.
@nl
P2860
P1476
Heat shock protein as molecular targets for breast cancer therapeutics.
@en
P2093
Jun Ho Kim
Lee Su Kim
P2860
P304
P356
10.4048/JBC.2011.14.3.167
P577
2011-09-29T00:00:00Z